DRUG BENEFIT INTEGRITY

The $400 Billion Verification Gap

Drug Benefit Integrity is the independent standard for evaluating whether pharmacy benefit decisions are made - and verified - in the plan's interest.

The Problem

In today's pharmacy benefit structure, the entities making routing decisions often have financial relationships with the dispensing channels being evaluated. Manufacturer-funded programs - while valuable - frequently operate outside the benefit, creating gaps in visibility and coordination.

Transparency shows what happened. Integrity proves it happened right.

Transparency vs. Integrity

Transparency

  • Shows what happened after the fact
  • Produced by the entity that made the decision
  • Structural overlap remains

Integrity

  • Ensures it happened right in the first place
  • Produced by an independent party with no channel interest
  • Structural independence is built in

Who Benefits

Plan Fiduciaries

Independent documentation meeting ERISA prudent expert standards and CAA audit requirements.

Benefits Consultants

A structural standard that changes the question from “Is this a good deal?” to “Does this have integrity?”

PBMs & Health Plans

A competitive differentiator. Independent verification demonstrates operational integrity to clients and prospects.

Stay informed. Get the monthly State of Drug Benefit Integrity report.